330 related articles for article (PubMed ID: 1588145)
21. Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines. The Vaccine Study Group.
Schlesinger Y; Granoff DM
JAMA; 1992 Mar; 267(11):1489-94. PubMed ID: 1538539
[TBL] [Abstract][Full Text] [Related]
22. G2m(23) immunoglobulin allotype and immunity to Haemophilus influenzae type b.
Granoff DM; Holmes SJ
J Infect Dis; 1992 Jun; 165 Suppl 1():S66-9. PubMed ID: 1588180
[TBL] [Abstract][Full Text] [Related]
23. IgG1, IgG2 and IgM responses to two Haemophilus influenzae type b conjugate vaccines in young infants.
Ambrosino DM; Sood SK; Lee MC; Chen D; Collard HR; Bolon DL; Johnson C; Daum RS
Pediatr Infect Dis J; 1992 Oct; 11(10):855-9. PubMed ID: 1408486
[TBL] [Abstract][Full Text] [Related]
24. Comparative immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugate vaccines.
Granoff DM; Holmes SJ
Vaccine; 1991 Jun; 9 Suppl():S30-4; discussion S42-3. PubMed ID: 1891954
[TBL] [Abstract][Full Text] [Related]
25. High antibody responses to booster doses of either Haemophilus influenzae capsular polysaccharide or conjugate vaccine after primary immunization with conjugate vaccines.
Käyhty H; Eskola J; Peltola H; Saarinen L; Mäkelä PH
J Infect Dis; 1992 Jun; 165 Suppl 1():S165-6. PubMed ID: 1588156
[No Abstract] [Full Text] [Related]
26. Impaired antibody response to Haemophilus influenzae type b polysaccharide and low IgG2 and IgG4 concentrations in Apache children.
Siber GR; Santosham M; Reid GR; Thompson C; Almeido-Hill J; Morell A; deLange G; Ketcham JK; Callahan EH
N Engl J Med; 1990 Nov; 323(20):1387-92. PubMed ID: 2233905
[TBL] [Abstract][Full Text] [Related]
27. Haemophilus influenzae type B conjugate vaccines.
Force RW; Lugo RA; Nahata MC
Ann Pharmacother; 1992 Nov; 26(11):1429-40. PubMed ID: 1477450
[TBL] [Abstract][Full Text] [Related]
28. Immunoglobulin variable region gene expression in response to Haemophilus influenzae type b polysaccharide.
Carroll WL; Adderson EE; Quinn A; Shackelford PG
J Infect Dis; 1992 Jun; 165 Suppl 1():S57-61. PubMed ID: 1588178
[TBL] [Abstract][Full Text] [Related]
29. Haemophilus influenzae type b carriage and immunity four years after receiving the Haemophilus influenzae oligosaccharide-CRM197 (HbOC) conjugate vaccine.
Barbour ML; Booy R; Crook DW; Griffiths H; Chapel HM; Moxon ER; Mayon-White D
Pediatr Infect Dis J; 1993 Jun; 12(6):478-84. PubMed ID: 8345980
[TBL] [Abstract][Full Text] [Related]
30. Safety and immunogenicity of haemophilus influenzae type B polysaccharide or conjugate vaccines in an elderly adult population.
Lottenbach KR; Granoff DM; Barenkamp SJ; Powers DC; Kennedy D; Irby-Moore S; Homan SM; Mink CM
J Am Geriatr Soc; 2004 Nov; 52(11):1883-7. PubMed ID: 15507066
[TBL] [Abstract][Full Text] [Related]
31. Haemophilus influenzae b polysaccharide revaccination: a continued role for the unconjugated vaccine.
Pichichero ME; Bracikowski A; Sullivan R; Madore D; Anderson P
Pediatr Infect Dis J; 1989 Jan; 8(1):20-3. PubMed ID: 2784202
[TBL] [Abstract][Full Text] [Related]
32. Characterization of the human IgG antibody VL repertoire to Haemophilus influenzae type b polysaccharide.
Scott MG; Nahm MH
J Infect Dis; 1992 Jun; 165 Suppl 1():S53-6. PubMed ID: 1375255
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of bacterial polysaccharide immune globulin for the treatment or prevention of Haemophilus influenzae type b and pneumococcal disease.
Siber GR; Thompson C; Reid GR; Almeido-Hill J; Zacher B; Wolff M; Santosham M
J Infect Dis; 1992 Jun; 165 Suppl 1():S129-33. PubMed ID: 1588146
[TBL] [Abstract][Full Text] [Related]
34. Depression of anticapsular antibody after immunization with Haemophilus influenzae type b polysaccharide-diphtheria conjugate vaccine.
Marchant CD; Band E; Froeschle JE; McVerry PH
Pediatr Infect Dis J; 1989 Aug; 8(8):508-11. PubMed ID: 2788860
[TBL] [Abstract][Full Text] [Related]
35. Characterization of the serum antibody response to the capsular polysaccharide of Haemophilus influenzae type b in children with invasive infections.
Trollfors B; Lagergård T; Claesson BA; Thornberg E; Martinell J; Schneerson R
J Infect Dis; 1992 Dec; 166(6):1335-9. PubMed ID: 1431250
[TBL] [Abstract][Full Text] [Related]
36. Disease caused by Haemophilus influenzae type b in the immediate period after homologous immunization: immunologic investigation.
Sood SK; Daum RS
Pediatrics; 1990 Apr; 85(4 Pt 2):698-704. PubMed ID: 2107522
[TBL] [Abstract][Full Text] [Related]
37. National Advisory Committee on Immunization (NACI). Statement on Haemophilus influenzae type B conjugate vaccines for use in infants and children.
Can Commun Dis Rep; 1992 Dec; 18(23):169-76. PubMed ID: 1291012
[TBL] [Abstract][Full Text] [Related]
38. Hemophilus influenzae type B disease in children vaccinated with type B polysaccharide vaccine.
Granoff DM; Shackelford PG; Suarez BK; Nahm MH; Cates KL; Murphy TV; Karasic R; Osterholm MT; Pandey JP; Daum RS
N Engl J Med; 1986 Dec; 315(25):1584-90. PubMed ID: 3491315
[TBL] [Abstract][Full Text] [Related]
39. Prevention of Haemophilus influenzae type b colonization by vaccination: correlation with serum anti-capsular IgG concentration.
Fernandez J; Levine OS; Sanchez J; Balter S; LaClaire L; Feris J; Romero-Steiner S
J Infect Dis; 2000 Nov; 182(5):1553-6. PubMed ID: 11023481
[TBL] [Abstract][Full Text] [Related]
40. IgG subclass response to immunization with Haemophilus influenzae type b polysaccharide-outer membrane protein conjugate vaccine.
Granoff DM; Weinberg GA; Shackelford PG
Pediatr Res; 1988 Aug; 24(2):180-5. PubMed ID: 3263612
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]